• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Dec22
UBS Gives Anzhi Medicine a Buy Rating
02:30
Dec18
Zai Lab Ltd. Chief Legal Officer Reports Common Stock Disposition
21:35
Dec8
Zailabor Begins First-In-Human Phase 1/1B Study for ZL-1503
12:26
Nov25
Zai Lab's Chief Legal Officer Sells Company Common Stock
21:12
Nov11
UBS Maintains Buy Rating on Zai Lab Ltd With Price Target
00:36
Nov10
Zai Lab's Q3 Revenue Misses Expectations, Annual Guidance Cut
02:58

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 116.1 M, Net Income -35.96 M, EPS -0.3263

Zai Lab Limited (ZLAB.US/09688.HK) Q3 2025 Earnings Conference CallZai Lab Limited (ZLAB.US/09688.HK) Q3 2025 Earnings Conference Call
Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 109.98 M, Net Income -40.73 M, EPS -0.3729

May8
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 106.49 M, Net Income -48.44 M, EPS -0.4481

Zai Lab Limited (ZLAB.US/09688.HK) Q1 2025 Earnings Conference CallZai Lab Limited (ZLAB.US/09688.HK) Q1 2025 Earnings Conference Call
View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
31.500
+370.85%
+24.810
HXHX
1.290
+273.91%
+0.945
SIDU
2.290
+97.41%
+1.130
MGRT
12.440
+70.41%
+5.140
MENS
4.780
+50.55%
+1.605
HYMC
24.520
+49.33%
+8.100
VELO
15.590
+43.95%
+4.760
QBTX
51.760
+39.25%
+14.590
CMCT
4.310
+35.11%
+1.120
FLYT
22.750
+32.81%
+5.620
View More